Human immunodeficiency virus, diabetes mellitus and thyroid abnormalities: Should we be screening?

Southern African Journal of HIV Medicine

 
 
Field Value
 
Title Human immunodeficiency virus, diabetes mellitus and thyroid abnormalities: Should we be screening?
 
Creator Pillay, Somasundram Pillay, Davashni Singh, Deepak Pillay, Romashan
 
Subject Internal Medicine, Diabetology, HIV infection, Thyroid disorders, Public Health patients with diabetes mellitus; HIV infection; thyroid disorders; antiretroviral therapy; patient screening options
Description Background: Diabetes mellitus (DM) and human immunodeficiency virus (HIV) are associated with thyroid abnormalities. Scarce literature exists on the prevalence of thyroid abnormalities in people living with HIV (PLWH) and DM (PLWHD). Guidelines vary regarding thyroidstimulating hormone (TSH) screening in PLWH and/or DM.Objectives: This study describes thyroid abnormalities in PLWHD and HIV-uninfected people living with DM (PLWD).Method: This was a cross-sectional analysis of demographic, clinical and biochemical data including TSH results of first-visit patients to the Edendale Hospital diabetes clinic between January 2016 and December 2017.Results: A total of 915 patients were enrolled: 165 PLWHD and 750 PLWD. Overall prevalence of thyroid disorders in PLWD was 8.53% (64/750). The occurrence of ‘total’ thyroid disorders and of ‘subclinical-hypothyroidism’ (SCH) was higher in PLWHD than PLWD (23.03% vs. 8.53% and 20.61% vs. 4%, p 0.001; respectively). People living with HIV and diabetes withthyroid disorders had lower CD4 counts than PLWHD without thyroid disorders (376.08 ± 333.30 vs. 509 ± 341.7 cells/mm3; p = 0.004). Subclinical-hypothyroidism was more common in patients on antiretroviral therapy [ART] (27/136 [19.85%] vs. 4/27 [14.81%], p 0.001). A significant number of PLWHD acquired HIV before the onset of DM (107/165 [64.85%] vs. 58/165 [35.15%], p 0.001). Patients on ART were more likely to develop DM, OR 2.66 (95% CI 1.11–6.38).Conclusion: Our study showed an increased prevalence of thyroid disorders (especially SCH) in PLWD and a higher prevalence in PLWHD. Young, overweight, female PLWHD were at risk of SCH. People living with HIV and DM on ART demonstrated an increased prevalence of thyroid dysfunction and poor lipaemic control. The introduction of combined communicable–non-communicable disease clinics might provide an integrated patientscreening option.
 
Publisher AOSIS
 
Contributor none
Date 2020-11-09
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — This was a quantitative, descriptive, retrospective study where all demographic, clinical and biochemical data including TSH results were analysed for all first visit patients consulted at the Edendale Hospital diabetes clinic between 1 January 2016 till
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajhivmed.v21i1.1116
 
Source Southern African Journal of HIV Medicine; Vol 21, No 1 (2020); 8 pages 2078-6751 1608-9693
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajhivmed.org.za/index.php/hivmed/article/view/1116/2074 https://sajhivmed.org.za/index.php/hivmed/article/view/1116/2073 https://sajhivmed.org.za/index.php/hivmed/article/view/1116/2075 https://sajhivmed.org.za/index.php/hivmed/article/view/1116/2072
 
Coverage Pietermaritzburg, KwaZulu-Natal 2016-2017 Diabetes Mellitus, HIV infection, Thyroid Disorders, Age, gender, glycaemic control, lipid control
Rights Copyright (c) 2020 Somasundram Pillay, Davashni Pillay, Deepak Singh, Romashan Pillay https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT